- Home
- CANG vs NRXP Comparison
CANG vs NRXP Comparison
Compare CANG & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANG | NRXP |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | 96 | 29 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.5M | 99.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CANG | NRXP |
|---|---|---|
| Price | $0.29 | $3.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $38.25 |
| AVG Volume (30 Days) | 816.5K | ★ 1.7M |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $428.72 | $2,547.84 |
| Revenue Next Year | $18.39 | $1,591.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.29 | $1.65 |
| 52 Week High | $5.75 | $5.06 |
Technical Indicators
Market Signals| Indicator | CANG | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 30.73 | 54.14 |
| Support Level | N/A | $1.83 |
| Resistance Level | $0.50 | $5.06 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 0.93 | 34.82 |
Price Performance
Historical ComparisonAbout CANG Cango Inc. each representing two (2)
Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The operations are divided into two reportable segments (i) Bitcoin Mining Business and (ii) International Automobile Trading Business. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.